Table 2.
Mean values of FBS, lipid profile, HbA1cand BMI before and after the intervention in both groups (Data are mean ± SD)
| |
Experimental Group (n = 35) |
Control Group (n = 35) |
||
|---|---|---|---|---|
| Variables | Before treatment | After treatment | Before treatment | After treatment |
| FBS (mg/dl) * |
196 ± 100 |
127 ± 67 |
155 ± 83 |
196 ± 120 |
| TG (mg/dl) ** |
120 ± 54.55 |
108 ± 65.27 |
113 ± 43 |
138 ± 91 |
| TC (mg/dl) ** |
172 ± 25.78 |
172 ± 27.83 |
165 ± 32 |
178. ± 52 |
| LDL (mg/dl) ** |
107 ± 21.75 |
109 ± 24.91 |
102 ± 26 |
112 ± 35 |
| HDL (mg/dl) * |
42 ± 7.24 |
43 ± 9.45 |
42 ± 5.44 |
38 ± 8.04 |
| HbA1c (%)* |
8.24 ± 1.44 |
7.08 ± 1.26 |
8.3 ± 1.52 |
8.18 ± 2.05 |
| BMI ** | 20.99 ±2.65 | 21.09 ± 2.54 | 22.55 ± 4 | 22.87 ± 4 |
P*<0.05 p**>0.05 between two groups comparisons.
FBS, fasting blood sugar; TG, triglycerides; TC, total cholesterol; LDL, HDL, low and high density, Lipoprotein ; HbA1c, glycated Hemoglobin; BMI, body mass index.